Evidence map›Paper›PMID 33676579›Full record

ArticleParasites & vectors2021

Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA

Angela Di Cesare, Simone Morelli, Giulia Morganti, Giulia Simonato, Fabrizia Veronesi, Mariasole Colombo, Michele Berlanda, Wilfried Lebon, Matilde Gallo, Frederic Beugnet and 1 more

Open access · goldAbstract readClinical Trial, VeterinaryMulticenter StudyRandomized Controlled Trial, Veterinary
In one paragraph

Article in Parasites & vectors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Prevalence and Risk Factors forAnimals : an open access journal from MDPI · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Angela Di CesareFaculty of Veterinary Medicine, University of Teramo, 64100, Teramo, Italy.
Simone MorelliFaculty of Veterinary Medicine, University of Teramo, 64100, Teramo, Italy.
Giulia MorgantiDepartment of Veterinary Medicine, University of Perugia, 06126, Perugia, Italy.
Giulia SimonatoDepartment of Animal Medicine, Production and Health, University of Padua, 35020, Padua, Legnaro, Italy.
Fabrizia VeronesiDepartment of Veterinary Medicine, University of Perugia, 06126, Perugia, Italy.
Mariasole ColomboFaculty of Veterinary Medicine, University of Teramo, 64100, Teramo, Italy.
Michele BerlandaDepartment of Animal Medicine, Production and Health, University of Padua, 35020, Padua, Legnaro, Italy.
Wilfried LebonBoehringer-Ingelheim Animal Health, Lyon, France.
Matilde GalloFaculty of Veterinary Medicine, University of Teramo, 64100, Teramo, Italy.
Frederic BeugnetBoehringer-Ingelheim Animal Health, Lyon, France.
Donato TraversaFaculty of Veterinary Medicine, University of Teramo, 64100, Teramo, Italy. dtraversa@unite.it.
University of Teramo · ITUniversity of Padua · ITUniversity of Perugia · ITBoehringer Ingelheim (France) · FRDépartement Santé Animale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCapillaria aerophila and Capillaria boehmi parasitize the respiratory system of wild and domestic carnivores. Capillaria aerophila inhabits the trachea and bronchi of dogs and cats, while C. boehmi affects the nasal cavities and sinuses of dogs. In dogs the infection may be subclinical or characterized by varying respiratory distress.

methodsThe present study evaluated the efficacy of an oral formulation containing milbemycin oxime and afoxolaner (NEXGARD SPECTRA

resultsPercentage reduction of fecal Capillaria egg counts in the NEXGARD SPECTRA

conclusionsResults of the present study showed that NEXGARD SPECTRA® was safe and highly efficacious in the reduction of C. aerophila and C. boehmi eggs after one treatment with a complete reduction of the egg output after the second administration associated with a recovery from respiratory signs.

Indexed as

Administration, OralAnimalsAnthelminticsCapillariaDog DiseasesDogsEnoplida InfectionsIsoxazolesMacrolidesNaphthalenesTabletsafoxolanerAnthelminticsIsoxazolesMacrolidesmilbemycin oximeNaphthalenesTabletsCapillaria aerophilaCapillaria boehmiDogMilbemycin oximeNEXGARD SPECTRA®

Identifiers

PMID33676579
PMCPMC7937313
OpenAlexW3135765517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.